Over-expression of mir-181a-3p in serum of breast cancer patients as diagnostic biomarker
Molecular Biology Reports · 2024
DOI: 10.1007/s11033-024-09272-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Hadi Fouladi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Genetics, Tabriz, Iran. Hauptthemen laut MEDLINE: Breast Neoplasms, MicroRNAs. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Tabriz University of Medical Sciences.
Themen: Onkologische Pflege
Abstract (Originalsprache)
BACKGROUND: Recently, the significance of epigenetics, particularly in breast cancer (BC), has become increasingly recognized. MicroRNAs (miRNAs), as an epigenetic factor, are offering valuable insights into various aspects of BC, such as its origins and clinical features. Therefore, studying the disruption of specific miRNAs through microarray and RNA-seq techniques is considered useful. METHODS AND MATERIALS: We analyzed two microarray datasets (GSE106817 and GSE113486) in order to discover dysregulated miRNAs in the serum of BC patients. Subsequently, RNA-seq analysis was employed on the TCGA data. Two miRNAs, mir-450a-5p and mir-181a-3p, as novel miRNAs in BC studies, were selected for assessment in the serum of 100 BC patients versus 100 healthy female participants. The quantities of the miRNAs described above were determined through the utilization of RT-qPCR. Furthermore, ROC curve assessments were conducted for each individual miRNA. Next, an assessment was conducted to determine the prognostic significance of these miRNAs. CONCLUSIONS: In summary, the utilization of microarray and RNA-seq analysis techniques has demonstrated that mir-450a-5p and mir-181a-3p exhibit elevated expression levels in the serum of BC patients. However, it is noteworthy that only mir-181a-3p displayed clinical dysregulation, as confirmed by RT-PCR findings. These miRNAs have been found to play a crucial role in modulating essential cellular processes and biological functions that contribute to cancer development. Furthermore, noteworthy outcomes have been observed for mir-181a-3p in relation to diagnostic and prognostic clinical characteristics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Genetics, Tabriz, Iran.
- Department of Medical Genetics, Faculty of Medicine, Tabriz University of Medical Genetics, Tabriz, Iran. shekarima@tbzmed.ac.ir.
Förderung
- Tabriz University of Medical Sciences
Zitieren
APA
Fouladi, H., Ebrahimi, A., Derakhshan, S. M., & Khaniani, M. S. (2024). Over-expression of mir-181a-3p in serum of breast cancer patients as diagnostic biomarker. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09272-4
Vancouver
Fouladi H, Ebrahimi A, Derakhshan SM, Khaniani MS. Over-expression of mir-181a-3p in serum of breast cancer patients as diagnostic biomarker. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-09272-4
BibTeX
@article{Fouladi2024,
author = {Fouladi, Hadi and Ebrahimi, Amir and Derakhshan, Sima Mansoori and Khaniani, Mahmoud Shekari},
title = {Over-expression of mir-181a-3p in serum of breast cancer patients as diagnostic biomarker},
journal = {Molecular Biology Reports},
year = {2024},
doi = {10.1007/s11033-024-09272-4}
}
EUVIMED